Choidas; Axel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Choidas; Axel.The latest application filed is for "coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer".

Company Profile

3.9.22

Choidas; Axel - Herdecke DE
Choidas; Axel - Gauting DE
Choidas; Axel - Buchendorf/Gauting DE
Choidas, Axel - Munich DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer Grant 11,111,238 - Di Lucrezia , et al. September 7, 2	2021-09-07
Coumarin Derivatives, Processes For Their Preparation And Uses Thereof For The Treatment Of Cancer App 20200291011 - Di Lucrezia; Raffaella ; et al.	2020-09-17
4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer Grant 10,703,735 - Di Lucrezia , et al.	2020-07-07
4-phenyl-coumarin Derivatives, Processes For Their Preparation And Uses Thereof For The Treatment Of Cancer App 20200031794 - Di Lucrezia; Raffaella ; et al.	2020-01-30
Pharmaceutically active disubstituted pyridine derivatives Grant 9,242,937 - Ruhter , et al. January 26, 2	2016-01-26
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20150329537 - Choidas; Axel ; et al.	2015-11-19
Pharmaceutically active compounds as Axl inhibitors Grant 8,999,982 - Schultz-Fademrecht , et al. April 7, 2	2015-04-07
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20140303167 - Choidas; Axel ; et al.	2014-10-09
Pharmaceutically Active Disubstituted Pyridine Derivatives App 20140296304 - Ruhter; Gerd ; et al.	2014-10-02
Susceptibility To Selective Cdk9 Inhibitors App 20140287454 - Choidas; Axel ; et al.	2014-09-25
Pharmaceutically Active Compounds As Axl Inhibitors App 20140018365 - Schultz-Fademrecht; Carsten ; et al.	2014-01-16
4,6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20130338147 - Wabnitz; Philipp ; et al.	2013-12-19
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases Grant 8,507,498 - Wabnitz , et al. August 13, 2	2013-08-13
Pharmaceutically Active Disubstituted Triazine Derivatives App 20130079345 - Eickhoff; Jan ; et al.	2013-03-28
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases Grant 8,084,457 - Choidas , et al. December 27, 2	2011-12-27
4, 6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20110306602 - Wabnitz; Philipp ; et al.	2011-12-15
Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor App 20090298842 - Pato; Janos ; et al.	2009-12-03
4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections App 20090018149 - Missio; Andrea ; et al.	2009-01-15
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases App 20070191344 - Choidas; Axel ; et al.	2007-08-16
Pharmaceutically active aromatic guanylhydrazones App 20050171176 - Bevec, Dorian ; et al.	2005-08-04
Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor App 20040171603 - Pato, Janos ; et al.	2004-09-02
Pharmaceutically active aromatic guanylhydrazones App 20030203969 - Bevec, Dorian ; et al.	2003-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.